Melo, A. M., Conroy, M. J., Foley, E. K., Dockry, É., Breen, E. P., Reynolds, J. V., . . . Doherty, D. G. (2020). CD1d expression and invariant natural killer T-cell numbers are reduced in patients with upper gastrointestinal cancers and are further impaired by commonly used chemotherapies. Cancer Immunology, Immunotherapy, 69(6), 969. https://doi.org/10.1007/s00262-020-02514-x
Chicago Style (17th ed.) CitationMelo, Ashanty M., Melissa J. Conroy, Emma K. Foley, Éilis Dockry, Eamon P. Breen, John V. Reynolds, Joanne Lysaght, and Derek G. Doherty. "CD1d Expression and Invariant Natural Killer T-cell Numbers Are Reduced in Patients with Upper Gastrointestinal Cancers and Are Further Impaired by Commonly Used Chemotherapies." Cancer Immunology, Immunotherapy 69, no. 6 (2020): 969. https://doi.org/10.1007/s00262-020-02514-x.
MLA (9th ed.) CitationMelo, Ashanty M., et al. "CD1d Expression and Invariant Natural Killer T-cell Numbers Are Reduced in Patients with Upper Gastrointestinal Cancers and Are Further Impaired by Commonly Used Chemotherapies." Cancer Immunology, Immunotherapy, vol. 69, no. 6, 2020, p. 969, https://doi.org/10.1007/s00262-020-02514-x.
